Yes, GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound) reduce cholesterol levels alongside promoting weight loss
This paper reviews the evidence related to oral semaglutide decreasing cardiovascular risk in patients with type 2 diabetes, focusing on the drugs antiatherosclerotic properties
The New England Journal of Medicine
Consequently, exposure to CPA leads to enzymatic cleavage of the C-terminal end of albumin, reducing its binding to FcRn, as previously reported 60
The cells were washed three times with secretion buffer (4.5 mM KCl, 138 mM NaCl, 4.2 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , 2.6 mM CaCl 2 , 1.2 mM MgCl 2 , and 10 mM HEPES, which was adjusted to pH 7.4 with NaOH) supplemented with 0.1% fatty acid-free bovine albumin serum (BSA